Murae Organisor Ltd (MURAE) – Share Price & Analysis

Price ₹0.19, Market Cap 57.26 (Cr), P/E 3.77x. Score: 47.4/100.

Financial Ratios PE Ratio Shareholding Dividend Quarterly Results Financial Statements

Murae Organisor Ltd Stock Price Today (NSE: MURAE)

Murae Organisor Ltd

MURAEPharmaceuticals

₹0.19+₹0.00 (+0.00%)

As on 19 Jun 2026, 11:00 am ISTMarket Open

Fundamental Score

...

Murae Organisor Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Q: What is the current share price of Murae Organisor Ltd?

Murae Organisor Ltd (MURAE) trades at ₹0.19 on NSE and BSE. Market cap ₹57.26 (Cr). Educational data only.

Q: What is the P/E ratio of Murae Organisor Ltd?

Murae Organisor Ltd has a P/E of 3.77x vs industry average 31.77x.

Q: What is the Bull Run score for Murae Organisor Ltd?

Murae Organisor Ltd has a Bull Run score of 47.4/100 based on 25+ financial parameters.

Q: Does Murae Organisor Ltd pay dividends?

Murae Organisor Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

Q: What is the ROE of Murae Organisor Ltd?

Murae Organisor Ltd has ROE of 5.69%. Higher ROE indicates better use of shareholder equity.

Q: What is the debt-to-equity ratio of Murae Organisor Ltd?

Murae Organisor Ltd has debt-to-equity of 1.02.

Q: Is Murae Organisor Ltd a good investment?

Bull Run gives Murae Organisor Ltd a score of 47.4/100. This is not investment advice — consult a SEBI-registered advisor.

Murae Organisor Ltd share price today is ₹0.19, up +0.00% on NSE/BSE as of 19 June 2026. Murae Organisor Ltd (MURAE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹57.26 (Cr). The 52-week high for MURAE share price is ₹0.97 and the 52-week low is ₹0.19. At a P/E ratio of 3.77x, MURAE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 5.69% and a debt-to-equity ratio of 1.02.

Murae Organisor Ltd Share Price Chart — NSE/BSE Historical Performance

No data

High

₹0.19

Low

₹0.19

Volume

Change

+0.00%

Murae Organisor Ltd — Last 10 Trading Days

Date	Open	High	Low	Close
1 Jun 26	₹0.19	₹0.19	₹0.19	₹0.19
29 May 26	₹0.19	₹0.19	₹0.19	₹0.19
28 May 26	₹0.19	₹0.19	₹0.19	₹0.19
27 May 26	₹0.19	₹0.19	₹0.19	₹0.19
26 May 26	₹0.19	₹0.19	₹0.19	₹0.19
25 May 26	₹0.19	₹0.19	₹0.19	₹0.19
22 May 26	₹0.19	₹0.19	₹0.19	₹0.19
21 May 26	₹0.19	₹0.19	₹0.19	₹0.19
20 May 26	₹0.19	₹0.19	₹0.19	₹0.19
19 May 26	₹0.19	₹0.19	₹0.19	₹0.19

Murae Organisor Ltd — Last 12 Months Price History

Month	Open	High	Low	Close	Change
Jun 2026	₹0.19	₹0.19	₹0.19	₹0.19	+0.00%
May 2026	₹0.19	₹0.19	₹0.19	₹0.19	+0.00%
Apr 2026	₹0.19	₹0.19	₹0.19	₹0.19	+0.00%
Mar 2026	₹0.21	₹0.22	₹0.19	₹0.19	-9.52%
Feb 2026	₹0.21	₹0.27	₹0.20	₹0.22	+4.76%
Jan 2026	₹0.26	₹0.28	₹0.20	₹0.20	-23.08%
Dec 2025	₹0.28	₹0.31	₹0.24	₹0.26	-7.14%
Nov 2025	₹0.26	₹0.32	₹0.26	₹0.28	+7.69%
Oct 2025	₹0.55	₹0.55	₹0.27	₹0.27	-50.91%
Sept 2025	₹0.73	₹0.79	₹0.56	₹0.57	-21.92%
Aug 2025	₹0.74	₹0.74	₹0.53	₹0.70	-4.94%
Jul 2025	₹0.88	₹0.88	₹0.77	₹0.77	-12.37%

AI Research Briefing

Murae Organisor is a micro-cap value trap with a disastrous balance sheet and a high-risk diversification strategy.

Research Confidence

9.0/10High

MICRO-CAP DARK HORSEConsistent breakdown. 3M: -63.16%, 6M: -69.89%P/E of 3.77x looks cheap vs. industry P/E of 31.77x, but earnings quality is suspect.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Murae Organisor Ltd hit an all-time low of on March 25, 2026, despite a recent uptick in quarterly profits. Year-to-date, the stock is down 85.5%. Recent quarterly results showed net sales surged to s, reflecting a 225,778% growth rate. Profit after tax (PAT) for the quarter reached s, a 295.7% increase.

CORE STORY (THE REAL GAME)

This is a micro-cap stock trading on hope, not fundamentals. The market is pricing in a turnaround story based on aggressive expansion into the agro-commodity sector, ignoring the brutal reality of its balance sheet and consistent underperformance.

WHAT IS DRIVING THE STOCK

Agro-Commodity Expansion: The company is investing -25 crore in agricultural land in Kutch, Gujarat, to cultivate pomegranates and set up a distillery.

Exceptional Quarterly Growth: Recent quarterly results showed net sales surged to s, reflecting a 225,778% growth rate. Profit after tax (PAT) for the quarter reached s, a 295.7% increase.

BULL vs BEAR

Bull:Agro expansion delivers, margins improve, and the company becomes a legitimate player in the agri-commodity space.

Bear:Micro-cap with a history of losses, questionable governance, and now diversifying into a completely different sector. Balance sheet is a disaster. Stock is already at all-time lows.

WHAT MARKET IS PRICING

The market is pricing in a successful turnaround and agro-commodity boom. Reality check

BOTTOM LINE

This stock is a value trap dressed up as a growth story. Avoid.

Why Now

Agro-commodity expansion plans
Recent surge in quarterly sales and profit
Low P/E ratio relative to industry

Potential Catalysts

Successful integration of agro-business
Significant order wins in the pharma or agro sector
Major debt restructuring

Key Risks

Micro/SME cap = liquidity risk
Negative free cash flow of ₹-343.64 Cr
Promoter holding is 0%

Institutional Activity

No institutional holding. Retail bagholders only.

Macro Context

Indian pharma sector is shifting towards value-led innovation in biologics and biosimilars, but Murae is focused on generics and agro commodities.

Order Book / Expansion

Company accumulated supply orders of ₹297 Crores in agro commodities in June 2025.

Cash Flow Quality

No. Free Cash Flow 5Y: ₹-343.64 Cr

3–6 Month Outlook

Agro expansion is a high-risk gamble. Pharma business is commoditized. Expect continued value destruction.

Primary Thesis Risk

Agro expansion fails, and the company collapses under its debt.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

5.69%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

4.20%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

-0.18%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Murae Organisor Ltd Valuation Check

Excellent

Price to Earnings (P/E)

3.77x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.77x

Average P/E of all peers in this sector

Market-cap Classification

Small-cap

Higher growth potential with higher volatility.

Market Capitalisation

57.26 (Cr)

Total market value of all outstanding shares

Shareholding Pattern

Poor

Promoter Holding

0.00%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

3200.00%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

1634.78%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

73.03%

Compounded annual revenue growth over 5 years

Good

EPS Growth (5-Year CAGR)

12.83%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

32.81%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.02x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-343.64 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Murae Organisor Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MURAE across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Attractive Valuation (P/E: 3.77 vs Industry: 31.77)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (3200.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (1634.78%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (73.03% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (32.81% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (5.69%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (4.20%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-0.18%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Elevated Debt Levels (D/E: 1.02)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Negative Free Cash Flow (₹-343.64 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (0.00%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Murae Organisor Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Murae Organisor Ltd with 10 other companies in the same sector

11 companies

Company Info	Fundamental Overall score	Valuation Price metrics	Profitability Return metrics		Financial Health Debt management	Growth 5Y performance		Dividend Yield %
Company Company name	Score Bull Run comprehensive fundamental score based on 20+ metrics	Price Current trading price of the stock	Market Cap Total value of all shares in the market	P/E Price per share divided by earnings per share	ROE Net income divided by shareholder equity	ROCE Earnings before interest and tax divided by capital employed	Debt/Eq Total debt divided by total equity	Profit 5Y Average annual profit growth over 5 years	Sales 5Y Average annual sales growth over 5 years	Dividend Annual dividend per share divided by price per share
Murae Organisor LtdMurae Organisor...Selected✓ MURAE • 542724	47.4/100	₹0.19₹0	₹57.26₹57.26	3.77Average 3.8 Average	5.69%Poor 5.69% Poor	4.20%Poor 4.20% Poor	1.02Average 1.0 Average	32.81%Excellent 32.81% Excellent	73.03%Excellent 73.03% Excellent	0.00%
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715	65.2/100	₹1844.30₹1844	₹433738.68₹433738.68	37.57Average 37.6 Average	16.86%Good 16.86% Good	20.21%Excellent 20.21% Excellent	0.07Excellent 0.1 Excellent	23.78%Excellent 23.78% Excellent	9.87%Good 9.87% Good	0.89%
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488	67.9/100	₹6797.50₹6798	₹170445.88₹170445.88	68.59Average 68.6 Average	15.35%Good 15.35% Good	20.44%Excellent 20.44% Excellent	0.01Excellent 0.0 Excellent	10.41%Good 10.41% Good	11.65%Good 11.65% Good	0.47%
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420	65.3/100	₹4537.80₹4538	₹126430.62₹126430.62	58.36Average 58.4 Average	26.52%Excellent 26.52% Excellent	27.05%Excellent 27.05% Excellent	0.33Excellent 0.3 Excellent	13.84%Good 13.84% Good	7.72%Good 7.72% Good	0.86%
Cipla LtdCipla Ltd... CIPLA • 500087	59/100	₹1418.20₹1418	₹123059.76₹123059.76	22.62Average 22.6 Average	17.77%Good 17.77% Good	22.72%Excellent 22.72% Excellent	0.01Excellent 0.0 Excellent	28.68%Excellent 28.68% Excellent	9.97%Good 9.97% Good	0.85%
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124	59.2/100	₹1319.00₹1319	₹105224.96₹105224.96	18.23Average 18.2 Average	17.96%Good 17.96% Good	22.69%Excellent 22.69% Excellent	0.16Excellent 0.2 Excellent	22.28%Excellent 22.28% Excellent	13.26%Good 13.26% Good	0.63%
Lupin LtdLupin Ltd... LUPIN • 500257	66.7/100	₹2276.40₹2276	₹95148.15₹95148.15	22.00Average 22.0 Average	20.62%Excellent 20.62% Excellent	21.30%Excellent 21.30% Excellent	0.32Excellent 0.3 Excellent	54.88%Excellent 54.88% Excellent	8.11%Good 8.11% Good	0.58%
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321	68.7/100	₹956.95₹957	₹94253.78₹94253.78	18.74Average 18.7 Average	21.21%Excellent 21.21% Excellent	24.31%Excellent 24.31% Excellent	0.38Excellent 0.4 Excellent	25.92%Excellent 25.92% Excellent	10.27%Good 10.27% Good	1.17%
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904	50.6/100	₹2420.40₹2420	₹92012.53₹92012.53	52.62Average 52.6 Average	14.68%Average 14.68% Average	15.98%Good 15.98% Good	0.55Good 0.6 Good	11.73%Good 11.73% Good	15.79%Excellent 15.79% Excellent	0.04%
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804	28.8/100	₹1435.90₹1436	₹70798.69₹70798.69	20.69Average 20.7 Average	11.08%Average 11.08% Average	14.18%Average 14.18% Average	0.22Excellent 0.2 Excellent	3.87%Average 3.87% Average	6.55%Good 6.55% Good	0.33%
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523	59.5/100	₹5451.50₹5452	₹67075.29₹67075.29	28.54Average 28.5 Average	19.39%Good 19.39% Good	20.38%Excellent 20.38% Excellent	0.18Excellent 0.2 Excellent	13.93%Good 13.93% Good	9.21%Good 9.21% Good	0.80%

Top Pharmaceuticals Stocks

View all →

By Bull Run Score

By Return on Equity

Torrent Pharmaceuticals Ltd share price26.52%
Zydus Lifesciences Ltd share price21.21%
Lupin Ltd share price20.62%
Alkem Laboratories Ltd share price19.39%
Dr Reddys Laboratories Ltd share price17.96%

By Market Cap

Sun Pharmaceutical Industries Ltd share price433738.68 Cr
Divis Laboratories Ltd share price170445.88 Cr
Torrent Pharmaceuticals Ltd share price126430.62 Cr
Cipla Ltd share price123059.76 Cr
Dr Reddys Laboratories Ltd share price105224.96 Cr

Murae Organisor Ltd PE Ratio History

Historical price-to-earnings ratio for MURAE — last 5 years

Year	EPS (₹)	Price (₹)	P/E Ratio
FY 2023	₹0.31	₹0.52	1.7x
FY 2022	₹0.30	₹1.33	4.5x
FY 2021	₹0.01	₹4.59	794x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Murae Organisor Ltd Quarterly Performance

Latest quarterly metrics for MURAE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

1634.78%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

3200.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

73.03%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

32.81%

Compounded annual net profit growth over 5 years

Murae Organisor Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MURAE — calculated from daily price history

Overbought — RSI 100

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50

₹0

▼ Price below SMA 50 — Short-term bearish

SMA 200

₹0

▼ Price below SMA 200 — Long-term downtrend

Technical indicators are for educational purposes only. Not investment advice.

Murae Organisor Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Murae Organisor Ltd (MURAE) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Murae Organisor Ltd

About MURAE (Murae Organisor Ltd)

Murae Organisor Ltd (MURAE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a curre...nt market capitalisation of ₹57.26 (Cr). Murae Organisor Ltd has delivered a Return on Equity (ROE) of 5.69% and a ROCE of 4.20%. The debt-to-equity ratio stands at 1.02, reflecting the company's capital structure. Investors tracking MURAE share price can monitor key metrics including P/E ratio, promoter holding of 0.00%, and quarterly earnings growth.